NCT03651531 Comparison of Insulin Alone to Insulin With Metformin to Treat Gestational Diabetes Mellitus Status TERMINATED Phase PHASE3
NCT03639545 The Effects of Empagliflozin on Arterial Wall Characteristics Status UNKNOWN Phase PHASE4
NCT03629639 Metformin for Treatment of Psoriasis Combined With Disorders of Glucose and Lipid Metabolism Status UNKNOWN Phase PHASE4
NCT03618654 Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell Carcinoma Status COMPLETED Phase EARLY_PHASE1
NCT03617458 Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE2
NCT03608358 Safety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/Saxagliptin Status TERMINATED Phase PHASE3
NCT03606694 Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes Mellitus Status UNKNOWN Phase PHASE2
NCT03603912 Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF) Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT03600363 A Clinical Trial of Metformin in the Maintenance of Non-Hodgkin's Lymphoma Patients Status UNKNOWN Phase PHASE2
NCT03593707 Drug-Drug Interaction Study to Evaluate the Effect of PF-06865571 on Metformin Pharmacokinetics Status COMPLETED Phase PHASE1
NCT03593668 Effect and Safety of Benaglutide or Metformin in Patients With Simple Obesity Who Have Inadequate Weight Control Status UNKNOWN Phase PHASE4
NCT03590262 Effect of Metformin as add-on Therapy on Glycemic Control and Other Outcomes in Type 1 Diabetes Status UNKNOWN Phase PHASE4
NCT03570632 Metformin for Preeclampsia Prevention in Pregnant Women With Type 1 Diabetes Mellitus Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT03566225 Pioglitazone Versus Metformin as First Treatment in Infertile Women With Polycystic Ovary Syndrome Status COMPLETED Phase EARLY_PHASE1
NCT03529123 Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India) Status COMPLETED Phase PHASE3